Home > Boards > US OTC > Miscellaneous >

Axim Biotechnologies Inc. (AXIM)

Add AXIM Price Alert      Hide Sticky   Hide Intro
Moderator: TUXI, Blue Skys, BlindSquirrel
Search This Board: 
Last Post: 1/22/2022 4:48:57 PM - Followers: 104 - Board type: Free - Posts Today: 0

News updates July 23rd 2020
"The NeuCovix™ test was compared to a gold standard pseudovirus-based test. NeuCovix™ accurately classified serum from patients who strongly neutralized SARS-CoV-2 and serum from patients who poorly neutralized the virus. Additionally, NeuCovix™ did not cross-react with serum from patients with seasonal respiratory infections including seasonal coronaviruses, suggesting that the test has 100 percent specificity for COVID-19. 


July 15, 2020 08:30 ET Source: AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, July 15, 2020 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological research, today announced the development of NeuCovixTM, a rapid diagnostic test measuring levels of functional neutralizing antibodies that are believed to prevent SARS-CoV-2 from entering the host cells.

Unlike currently available serological COVID-19 tests that detect an antibody response to the virus, AXIM’s rapid 10-minute test measures a specific subpopulation of antibodies to block binding of the virus to host cell receptors. While there are expensive, time consuming laboratory tests that measure neutralizing antibodies, NeuCovixTM differs in that it is a portable, low cost, rapid point-of-care test with results in 10 minutes.

“We are hopeful our test fills an important need in these uncertain times. While other tests merely show whether someone was infected with coronavirus, we took it a step further by creating a test that stratifies individuals into those who have neutralizing antibodies, which are essential in preventing reinfection, and those who don’t. The test can be deployed for point of care use in convalescent plasma transfusions to severely ill patients and for evaluating efficacy of upcoming vaccines in generating protective antibodies,” said Sergei Svarovsky, PhD, MBA, AXIM’s CSO and co-inventor of NeuCovixTM.

An immediate application of NeuCovixTM, a point-of-care test, is to measure levels of neutralizing antibodies in convalescent plasma so that plasma with the highest levels of neutralizing antibodies can be identified and administered to patients fighting COVID-19.  Without this knowledge, many patients could be undertreated with non-neutralizing plasma and may not benefit from this treatment. 

Another application of NeuCovixTM is to help ensure that vaccines elicit high levels of neutralizing antibodies. When a vaccine is available, manufacturers can employ the NeuCovixTM rapid, point-of-care test to evaluate protective immune responses in vaccine recipients.

AXIM® Biotech CEO John W. Huemoeller II commented, Our goal was to make this test, accurate, fast and relatively inexpensive so it could serve as an ‘Immunity Passport port™’ for vaccine developers around the world as they begin larger Phase II and III clinical trials. We are optimistic that NeuCovixTM will be widely used, becoming the gold standard in assessing levels of immunity.

Doug Lake, Ph.D. and co-inventor of NeuCovixTM commented, “Everybody who recovers from COVID-19 makes antibodies against the virus, but since all antibodies are not created equal, you really want to know if the antibodies you make neutralize the virus. People who recover want to make sure they are protected from re-infection and that they won’t infect others.”

AXIM also announced the filing of a pre-Emergency Use Authorization Application (EUA) and has already initiated dialogue with the FDA in order to finalize its EUA submission. The intellectual property relating to the novel serological test is the subject of Provisional Patent Application No. 63/023,646 “Convalescent Plasma Testing and Treatment” filed on May 12, 2020. 

About AXIM® Biotechnologies
Founded in 2014, AXIM® Biotechnologies, Inc. (AXIM) is a vertically integrated oncology company developing rapid diagnostic tests for the early detection of cancer and proprietary small molecules drugs to treat cancer and block metastasis. The Company is also developing novel antibodies for therapeutic and diagnostic uses for oncological therapeutics. For more information, please visit www.AXIMBiotech.com.



Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
#2203  Sticky Note IgM and IgG are VERY general terms that BlindSquirrel 11/10/21 07:09:23 PM
#2752   Anyone know hw many shares of Axim Johnny BlindSquirrel 01/22/22 04:48:57 PM
#2751   (As an aside, I just noticed that less BlindSquirrel 01/22/22 04:25:34 PM
#2750   So what do you figure comes between now Blue Skys 01/22/22 02:52:15 PM
#2749   I checked the FDA's website again just a BlindSquirrel 01/22/22 12:25:47 AM
#2748   ....and "We The AXIM Investors" appreciate all of BlindSquirrel 01/21/22 01:36:53 AM
#2747   The rally was great! I got into Blue Skys 01/20/22 09:55:42 PM
#2746   Fiddy percent still ain’t too bad…. baldingcontrarian 01/20/22 09:08:56 PM
#2745   NOW I'M JEALOUS! BlindSquirrel 01/20/22 08:34:49 PM
#2744   Stressful times. BlindSquirrel 01/20/22 08:25:30 PM
#2742   I'm back from travels. At the rally Blue Skys 01/20/22 07:26:29 PM
#2741   If you are averaged in around a quarter, BlindSquirrel 01/20/22 06:49:53 PM
#2740   Added .22 to my pile of .26’s baldingcontrarian 01/20/22 06:40:00 PM
#2739   Oh no I got in around 6$ and baldingcontrarian 01/20/22 06:38:22 PM
#2738   Agreed, and to say it another way, if BlindSquirrel 01/20/22 06:24:48 PM
#2737   I like AXIM at these prices. I TexasMarvL 01/20/22 04:36:25 PM
#2736   further reason why big pharma has no interest gwsteller 01/20/22 04:09:04 PM
#2735   That rollout was supposed to happen in Q1 BlindSquirrel 01/20/22 10:47:55 AM
#2734   JaneyH, You may be right, but the company has TexasMarvL 01/20/22 09:08:29 AM
#2733   A good investor has to "know what they TexasMarvL 01/20/22 08:53:04 AM
#2732   do we see teens here - without much janeyH 01/20/22 08:50:59 AM
#2731   I was shilling hard since it was $6 baldingcontrarian 01/20/22 08:08:21 AM
#2730   Crypto is an acquired taste. baldingcontrarian 01/20/22 07:10:34 AM
#2729   They should use Greek Letters in their symbols, BlindSquirrel 01/19/22 08:48:27 PM
#2728   Clarification on the crypto mining companies. I am TexasMarvL 01/19/22 07:36:50 PM
#2727   I don't have a crypto wallet or anything TexasMarvL 01/19/22 07:26:40 PM
#2726   If you have been in LUNA since July TexasMarvL 01/19/22 07:04:12 PM
#2725   Crypto? Hell no. BlindSquirrel 01/19/22 06:58:56 PM
#2724   See terra analytics dot com it shows the baldingcontrarian 01/19/22 06:39:29 PM
#2723   I’ve been in Luna.x since July. baldingcontrarian 01/19/22 06:37:45 PM
#2722   Agreed, there is something very fishy going on, BlindSquirrel 01/19/22 11:11:46 AM
#2721   Stops are very effective but you must place Tiresias 01/19/22 10:01:23 AM
#2720   After 21 years of active trading I know baldingcontrarian 01/19/22 09:38:24 AM
#2719   There are lots of factors at work… baldingcontrarian 01/19/22 09:37:07 AM
#2718   They would need to know support and resistance Tiresias 01/19/22 09:12:46 AM
#2717   I think a MM would ‘know’ intuitively where baldingcontrarian 01/19/22 09:07:45 AM
#2716   Stop limit orders cannot be seen by market Tiresias 01/19/22 08:57:02 AM
#2713   May I call your attention to post #2622: BlindSquirrel 01/18/22 07:09:11 PM
#2711   I'm only counting FDA approved Dry Eye Disease TexasMarvL 01/18/22 03:32:55 PM
#2710   Agree with that sentiment...damn authoritarians mc73 01/18/22 02:32:55 PM
#2709   Applying "dream" to AXIM is not quite apropos, Tiresias 01/18/22 01:11:03 PM
#2708   I think the "I had a dream" was Tiresias 01/18/22 12:52:15 PM
#2705   it was stated..."and I am guessing "they" have Tiresias 01/18/22 11:59:41 AM
#2704   Damn, I am thinking $7 to $14 pps BlindSquirrel 01/18/22 11:51:49 AM
#2702   cmon T, enlighten us on how you would janeyH 01/18/22 09:33:44 AM
#2701   Kaptain78 Because of out of control Inflation, I TexasMarvL 01/18/22 09:26:10 AM
#2700   You are most welcome, Perhaps in the future Tiresias 01/18/22 09:10:46 AM
#2699   I think the FDA thinks that an at Kaptain78 01/18/22 08:03:54 AM
#2698   My thoughts are more along the lines of BlindSquirrel 01/17/22 10:48:05 PM
#2697   Good points, all taken. Thank you mc73 01/17/22 05:06:21 PM
#2696   Hopefully in 3 more months we won't still mc73 01/17/22 04:23:52 PM
Consent Preferences